Capturing a contradiction: T cells and the benign-to-malignant transition

Peter Westcott (left) runs an independent research group at Cold Spring Harbor Laboratory (NY, USA), which is interested in how cancer interacts with the immune system and other normal cells in the surrounding tissue, and how these interactions change throughout critical stages and transitions in cancer development. His group uses a combination of innovative mouse models and human specimens from the clinic to address these questions, applying cutting-edge techniques in genomics and molecular biology, such as single-cell and spatial transcriptomics. We caught up with Peter after his recent receipt of the Gertrude B. Elion Cancer Research Award at this year’s...